SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-031965
Filing Date
2019-11-05
Accepted
2019-11-05 18:53:27
Documents
1
Period of Report
2019-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4379
  Complete submission text file 0001127602-19-031965.txt   5821
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Issuer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 2099 PENNSYLVANIA AVENUE, NW 12TH FLOOR WASHINGTON DC 20006
Business Address
Graham Jonathan P (Reporting) CIK: 0001365306 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37702 | Film No.: 191194686